| Overview |
| bs-15568R-Cy5 |
| IGF2AS Polyclonal Antibody, Cy5 Conjugated |
| WB, IF(IHC-P), IF(IHC-F), IF(ICC) |
| Human |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human IGF2AS |
| 101-168/168 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| IGF2 Antisense Gene Protein 1; IGF2 Antisense RNA Non-Protein Coding; IGF2 Antisense RNA 1; IGF2 Antisense RNA; IGF2 AS1; IGF2AS; Insulin Like Growth Factor 2, Antisense; PEG8; IG2AS_HUMAN; PEG8/IGF2AS Protein; Putative Insulin-Like Growth Factor 2 Antisense Gene Protein 1. |
| This gene expresses a paternally imprinted antisense transcript of the insulin-like growth factor 2 gene. The transcript is overexpressed in Wilms' tumor. This gene is predicted to be non-coding because the predicted protein is not conserved in any other species and the majority of transcripts would be candidates for non-sense mediated decay (NMD) if a protein were expressed. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009] |
| Application Dilution |
| WB |
1:300-5000 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
Powered by Bioz